Skip to main content

Delivra Health Brands releases Q3 financial number showing positive adjusted EBITDA

Delivra Health Brands CEO Gord Davey joined Steve Darling from Proactive to announce the financial and operating results for the three and nine months ended March 31, 2024. The company reported a total net revenue from continued operations of $8,792, reflecting a 36% increase compared to the same period last year, driven by higher sales of Dream Water in the US and Canada, along with increased sales of LivRelief.

Additionally, Davey told Proactive, Delivra saw a healthy rise in its gross profit margin, reaching 52%, up from 44% in the same period last year. This improvement contributed to positive Adjusted EBITDA, attributed to management's focus on customer mix, gross profit margin enhancement, and efficient administrative and selling support functions.

Contact Details

Proactive North America

+1 604-688-8158

na-editorial@proactiveinvestors.com

Recent Quotes

View More
Symbol Price Change (%)
AMZN  205.75
+4.60 (2.29%)
AAPL  265.33
+1.45 (0.55%)
AMD  202.19
-0.89 (-0.44%)
BAC  53.22
+0.48 (0.91%)
GOOG  304.31
+1.49 (0.49%)
META  639.55
+0.26 (0.04%)
MSFT  401.38
+4.52 (1.14%)
NVDA  189.06
+4.09 (2.21%)
ORCL  157.10
+3.13 (2.03%)
TSLA  414.87
+4.24 (1.03%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.